Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Cutan Ocul Toxicol ; 37(3): 258-266, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29480078

RESUMEN

In the present investigation, the safety of novel combinational silver sulfadiazine-bFGF-loaded hydrogel was assured by performing acute skin irritation, sensitization, acute dermal toxicity, and eye irritation in compliance with the Organization for Economic Co-operation and Development guidelines. In the skin irritation study, placebo, test, and positive control (0.8% w/v aqueous solution of formaldehyde) were applied on New Zealand rabbits and monitored for abnormal skin responses including erythema and edema. The placebo and test formulation did not induce any adverse reactions and were classified as nonirritating materials. In the skin sensitization test, guinea pigs were sensitized by positive control (0.1% w/v 1-chloro-2,4-dinitrobenzene in 10% of propylene glycol as a standard skin sensitizing agent), placebo, and test formulations. Weak sensitization was observed in the placebo and test formulation treated groups. Additionally, acute dermal toxicity test was performed in Wistar rats, where no signs of toxicity were observed in biochemical, hematological, and histopathological studies. Moreover, the acute eye irritation test was carried out in rabbits and no abnormal clinical signs were evident in the cornea or iris. As a whole, these findings suggest that the hydrogel formulation does not cause any skin irritation, skin sensitizationand dermal toxic effects, and eye irritation following dermal and ocular applications, respectively. Therefore, all the findings obtained from this preclinical study indicated that this hydrogel formulation is nontoxic and safe for use in animal models.


Asunto(s)
Quemaduras/tratamiento farmacológico , Factor 2 de Crecimiento de Fibroblastos/efectos adversos , Hidrogeles/efectos adversos , Sulfadiazina de Plata/efectos adversos , Piel/efectos de los fármacos , Administración Cutánea , Administración Oftálmica , Animales , Antiinfecciosos Locales , Seguridad de Productos para el Consumidor/normas , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Ojo/efectos de los fármacos , Femenino , Guías como Asunto , Cobayas , Humanos , Masculino , Conejos , Ratas , Ratas Wistar , Pruebas Cutáneas/normas , Pruebas de Toxicidad Aguda/normas
2.
Regul Toxicol Pharmacol ; 89: 1-12, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28694170

RESUMEN

Ultraviolet (UV) radiation exposure has been known to cause irreparable damages to human skin. The daunting risk of UV radiation exposure faced by military personnel led to the development of a sunscreen formulation which has superior sun protection factor combined with the ability to counteract reactive oxygen species. The present work deals with the preclinical safety evaluation of the sunscreen formulation comprising of four US FDA approved UV filters; namely avobenzone, octinoxate, oxybenzone, titanium dioxide along with melatonin and pumpkin seed oil, via OECD protocols of assessing acute oral and dermal toxicity; skin sensitizing; skin irritating; ocular irritating and genotoxic potential. Both oral and dermal LD50 values were found to be ˃2000 mg/kg body weight in adult Wistar albino rats using acute dermal and oral toxicity tests. The sunscreen formulation was found to be non-sensitizing to the skin of guinea pigs and non-irritating to both skin and eyes of rabbits. The sunscreen formulation was also found to be non-mutagenic which was affirmed by a battery of genotoxicity and muagenicity assays. The results obtained from this preclinical study indicated that the sunscreen formulation is non toxic and safe in animal models. This study along with additional preclinical evaluations may serve as a basis for considering the formulation as a potential candidate for further trials to establish its efficacy, tolerability and applicability.


Asunto(s)
Cucurbita/química , Melatonina/toxicidad , Semillas/química , Quemadura Solar/prevención & control , Protectores Solares/toxicidad , Animales , Benzofenonas/toxicidad , Cinamatos/toxicidad , Evaluación Preclínica de Medicamentos , Cobayas , Propiofenonas/toxicidad , Ratas , Ratas Wistar , Protectores Solares/química , Titanio/toxicidad , Pruebas de Toxicidad
3.
Curr Drug Deliv ; 16(1): 26-41, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30227817

RESUMEN

Wound infections impose a remarkable clinical challenge that has a considerable influence on morbidity and mortality of patients, influencing the cost of treatment. The unprecedented advancements in molecular biology have come up with new molecular and cellular targets that can be successfully applied to develop smarter therapeutics against diversified categories of wounds such as acute and chronic wounds. However, nanotechnology-based diagnostics and treatments have achieved a new horizon in the arena of wound care due to its ability to deliver a plethora of therapeutics into the target site, and to target the complexity of the normal wound-healing process, cell type specificity, and plethora of regulating molecules as well as pathophysiology of chronic wounds. The emerging concepts of nanobiomaterials such as nanoparticles, nanoemulsion, nanofibrous scaffolds, graphene-based nanocomposites, etc., and nano-sized biomaterials like peptides/proteins, DNA/RNA, oligosaccharides have a vast application in the arena of wound care. Multi-functional, unique nano-wound care formulations have acquired major attention by facilitating the wound healing process. In this review, emphasis has been given to different types of nanomaterials used in external wound healing (chronic cutaneous wound healing); the concepts of basic mechanisms of wound healing process and the promising strategies that can help in the field of wound management.


Asunto(s)
Fármacos Dermatológicos/administración & dosificación , Portadores de Fármacos/química , Nanoestructuras/química , Cicatrización de Heridas/efectos de los fármacos , Infección de Heridas/terapia , Administración Cutánea , Enfermedad Crónica/epidemiología , Enfermedad Crónica/terapia , Humanos , Morbilidad , Piel/efectos de los fármacos , Piel/lesiones , Resultado del Tratamiento , Infección de Heridas/epidemiología
4.
Acta Trop ; 167: 216-230, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28040483

RESUMEN

Mosquito being the major medically important arthropod vector; requires utmost attention to reduce the sufferings and economic consequences of those living in the endemic regions. This is only possible by minimising the human-mosquito contact by an absolute preventing measure. However, unfortunately, such absolute measures are yet to be developed despite enormous efforts and huge investments worldwide. In the absence of vaccines for number of mosquito-borne diseases, repellents could be an attractive option for both military personal and civilians to minimise the risk of contacting different mosquito-borne diseases. However, to achieve this golden goal, the detailed knowledge of a particular repellent is must, including its mode of repellency and other relevant informations. Here, in the present article, an effort has been made to convey the best and latest information on repellents in order to enhance the knowledge of scientific community. The review offers an overview on mosquito repellents, the novel discoveries, and areas in need of attention such as novel repellent formulations and their future prospective.


Asunto(s)
Vectores Artrópodos/efectos de los fármacos , Culicidae/efectos de los fármacos , Repelentes de Insectos/uso terapéutico , Animales , Humanos , Estudios Prospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA